Seeing the person behind a cancer diagnosis is the focus of award-winning JGH research
Individuals with cancer need to be perceived primarily as people, and not as cases or a collection of symptoms. That’s the focus of a research paper whose JGH co-authors have been honoured with a Best Publication award by the Canadian Association of Nurses in Oncology.
Two researchers elected to Canadian Academy of Health Sciences
Two LDI researchers have been elected to the Canadian Academy of Health Sciences. Dr. Carmen Loiselle is Co-Director (Academic) of the Segal Cancer Centre. Dr. Cécile Rousseau’s career is dedicated to understanding the effects of organized violence on children and families.
From the archives: Segal Cancer Centre is launched to deliver comprehensive cancer care
In 2006, Health and Social Services Minister Philippe Couillard visited the newly completed Segal Cancer Centre to express his admiration for the JGH’s leadership in providing patients with a fully integrated system of cancer treatment and care.
Trying to find meaning in a life altered by advanced cancer
To enable advanced cancer patients to cope with difficulties at the end of life, JGH researchers hope to develop better psychological support through an intervention that helps individuals find meaning in their radically altered lives.
Applying artificial intelligence to cancer diagnosis
A pioneering research program is connecting artificial intelligence with the new field of radiomics to heighten the effectiveness of cancer treatment by gleaning as much information as possible from radiological imaging technology.
Determined cyclists rally for Ride’s 10th edition
Ten years after its debut, the Enbridge Ride to Conquer Cancer reached its landmark anniversary on July 7 and 8, with 1,308 participants raising more than $4.8 million for the Segal Cancer Centre and its partners across Quebec.
Cyclists on Cloud 9 after raising $4.1 million to fight cancer
After a demanding, 200-kilometre ride from Montreal to Quebec City, 1,100 cyclists in the 9th annual Enbridge Ride to Conquer Cancer raised $4.1 million for the JGH and its partners across Quebec.
Promising therapy for relapsed patients with aggressive form of lymphoma
A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.
Segal Cancer Centre joins the “Cancer Moonshot”
The Segal Cancer Centre is taking “one small step” that could lead to “one giant leap” in a metaphorical moonshot to conquer cancer.
Easing cancer survivors back into the work force
You’ve waged a tough battle against cancer—and you’ve won. Congratulations! But what happens now that you’re ready to go back to work?